每經(jing)AI快(kuai)訊，方盛制(zhi)藥（SH 603998，收盤價：8.03元）12月20日(ri)晚(wan)間發布公(gong)(gong)告稱，截至(zhi)本公(gong)(gong)告披露日(ri)，張慶華(hua)先(xian)生(sheng)直(zhi)接持(chi)(chi)有(you)公(gong)(gong)司(si)(si)的(de)(de)股(gu)(gu)份(fen)(fen)總(zong)(zong)數(shu)(shu)(shu)約(yue)為1.56億(yi)股(gu)(gu)，占(zhan)公(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)總(zong)(zong)數(shu)(shu)(shu)（約(yue)4.4億(yi)股(gu)(gu)）的(de)(de)35.49%；張慶華(hua)先(xian)生(sheng)質押(ya)(ya)的(de)(de)公(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)總(zong)(zong)數(shu)(shu)(shu)約(yue)為1.29億(yi)股(gu)(gu)，占(zhan)其直(zhi)接持(chi)(chi)有(you)公(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)總(zong)(zong)數(shu)(shu)(shu)的(de)(de)82.86%，占(zhan)公(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)總(zong)(zong)數(shu)(shu)(shu)的(de)(de)29.41%；張慶華(hua)先(xian)生(sheng)控股(gu)(gu)的(de)(de)湖南開(kai)舜投資(zi)(zi)咨詢有(you)限(xian)公(gong)(gong)司(si)(si)之控股(gu)(gu)子公(gong)(gong)司(si)(si)堆龍德(de)慶共(gong)(gong)生(sheng)創業投資(zi)(zi)管理有(you)限(xian)公(gong)(gong)司(si)(si)持(chi)(chi)有(you)公(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)數(shu)(shu)(shu)約(yue)為1443萬(wan)股(gu)(gu)，共(gong)(gong)生(sheng)投資(zi)(zi)質押(ya)(ya)的(de)(de)公(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)總(zong)(zong)數(shu)(shu)(shu)為0股(gu)(gu)；綜(zong)上，張慶華(hua)及其一(yi)致行動人(ren)共(gong)(gong)生(sheng)投資(zi)(zi)合計(ji)持(chi)(chi)有(you)公(gong)(gong)司(si)(si)約(yue)1.7億(yi)股(gu)(gu)，以此計(ji)算，張慶華(hua)及其一(yi)致行動人(ren)共(gong)(gong)生(sheng)投資(zi)(zi)合計(ji)質押(ya)(ya)的(de)(de)公(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)總(zong)(zong)數(shu)(shu)(shu)約(yue)為1.29億(yi)股(gu)(gu)，占(zhan)持(chi)(chi)股(gu)(gu)總(zong)(zong)數(shu)(shu)(shu)的(de)(de)75.84%。

2022年1至(zhi)6月份，方(fang)盛制藥的營業(ye)(ye)收(shou)入(ru)構成為：工業(ye)(ye)占(zhan)比76.49%，醫(yi)療行業(ye)(ye)占(zhan)比16.52%，醫(yi)藥商業(ye)(ye)占(zhan)比3.34%，其他(ta)占(zhan)比1.25%。

方(fang)盛制藥的(de)總裁、董事(shi)長均是周(zhou)曉莉，女，49歲，學歷背(bei)景為大(da)專。

截至(zhi)發稿(gao)，方盛制藥市值(zhi)為35億元。

道達號（daoda1997）“個股趨勢”提醒：
1. 近30日內共有1批機構對方盛制藥調研，合計調研的機構家數為22家。
更(geng)多個股趨勢(shi)信(xin)息(xi)，請(qing)搜(sou)索微信(xin)公(gong)眾(zhong)號(hao)“道達號(hao)”，回復(fu)“查(cha)詢”，領取免費查(cha)詢權限！

每(mei)經頭條(tiao)（nbdtoutiao）——

(記者 蔡鼎)

免責聲(sheng)明：本文內容與(yu)數據僅(jin)供參考(kao)，不構成投(tou)資建(jian)議，使(shi)用前請(qing)核實。據此操作，風險自擔。